Park DC, Halter JB. In press. Cognitive aging research: Implications for medical patients and medical practices. In: Processing of Medical Information in Aging Patients: Cognitive and Human Factors Perspective. Mahway, NJ: Lawrence Erlbaum, Inc.
Pollock BG. 1996. Clinical relevance of pharmacogenetic variations in drug metabolism in the elderly. Drug Information Journal 30:669–674.
Pollock BG, Mulsant BH. 1995. Antipsychotics in older patients: A safety perspective. Drugs and Aging 6:312–323.
Ruegg RG, Zisook S, Swerdlow NR. 1988. Depression in the aged: An overview. Psychiatric Clinics of North America 11(1):83–99.
Salzman C. 1993. Pharmacologic treatment of depression in the elderly. Journal of Clinical Psychiatry 54(Suppl):S23–S28.
Scharf S, Christophidis N. 1993. Prescribing for the elderly: Relevance of pharmacokinetics and pharmacodynamics . Medical Journal of Australia 158:395–402.
SHEP Cooperative Research Group. 1991. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Journal of the American Medical Association 265(24):3255–3264.
Shimokata H, Andres R, Coon PJ, Elahi D, Muller DC, Tobin JD. 1989. Studies in the distribution of body fat. II. Longitudinal effects of change in weight. International Journal of Obesity 13(4):455–464.
Stewart RB. 1993. Advances in pharmacotherapy: Depression in the elderly: Issues and advances in treatment. Journal of Clinical Pharmacy and Therapeutics 18(4):243– 253.
Stolarek I, Scott PJ, Caird FI. 1991. Physiological changes due to age. Implications for cardiovascular drug therapy. Drugs and Aging 1(6):467–476.
Wenger NK, ed. 1993. Inclusion of Elderly Individuals in Clinical Trials: Cardiovascular Disease and Cardiovascular Therapy as a Model. Kansas City, MO: Marion Merrell Dow, Inc.
White M, Roden R, Minobe W, Khan MF, Larrabee P, Wollmering M, Port JD, Anderson F, Campbell D, Feldman AM, et al. 1994. Age-related changes in beta-adrenergic neuroeffector systems in the human heart. Circulation 90(3):1225–1238.